New obesity treatment may help preserve muscle during weight loss
A new obesity treatment called retatrutide may help individuals lose weight while preserving muscle mass. Dr. Andrew Huberman discussed its benefits on a podcast, highlighting its triple-action mechanism compared to older weight-loss drugs. This treatment aims to reduce the side effects commonly associated with previous GLP-1 therapies.
- ▪Retatrutide is a triple agonist that activates receptors for GIP, GLP-1, and glucagon.
- ▪Unlike older medications, retatrutide may help preserve lean muscle during weight loss.
- ▪It is administered as a once-weekly subcutaneous injection in clinical trials.
Fox News — Latest files mainly under news. We currently carry 3,549 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | Fox News — Latest |
| Canonical URL | https://www.foxnews.com/health/new-obesity-treatment-may-help-preserve-muscle-weight-loss |
| Publication time | Wed, 20 May 2026 17:17:01 -0400 |
| Retrieval time | 2026-05-20T21:25:02.995Z |
| Last seen | 2026-05-20T21:25:02.995Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | RaS_h8nYsWeM |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
Health New obesity treatment may help preserve muscle during weight loss Andrew Huberman acknowledges retatrutide benefits but warns of gray-market suppliers By Khloe Quill Fox News Published May 20, 2026 5:17pm EDT Facebook Twitter Threads Flipboard Comments Print Email Add Fox News on Google close Video Wellness Week: A closer look into peptide treatments Fox News correspondent Alexandria Hoff reports on the safety and legality of peptides, found in GLP-1 weight loss drugs, on ‘Special Report.’ NEWYou can now listen to Fox News articles! During a recent episode of her podcast, Gwyneth Paltrow spoke with neuroscientist Dr. Andrew Huberman about retatrutide, a new advancement in GLP-1 (glucagon-like peptide-1) therapies.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Fox News — Latest.
Discussion
0 commentsMore from Fox News — Latest
